Analyst Ratings for [HEXO] HEXO Corp.

HEXO HEXO Corp.

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

HEXO Corp., through its subsidiary, HEXO Operations Inc., produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names. The company serves medical and adult-use markets. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. is headquartered in Gatineau, Canada.

1/27/22	Upgrades	Underperform Hold	X
HEXO HEXO Jefferies
$1.07 $0.53
12/15/21	Downgrades	Neutral Sec Underperform	X
HEXO HEXO CIBC
3/22/21	Upgrades	Mkt Perform Outperform	X
HEXO HEXO BMO Capital Markets
2/17/21	Upgrades	Neutral Sec Outperform	X
HEXO HEXO CIBC
6/25/19	Downgrades	Outperform Perform	X
HEXO HEXO Oppenheimer
6/17/19	Downgrades	Sec Outperform Neutral	X
HEXO HEXO CIBC
4/26/19	Initiated	Buy	X
HEXO HEXO Desjardins
4/17/19	Initiated	Buy	X
HEXO HEXO BofA/Merrill
2/25/19	Initiated	Underperform	X
HEXO HEXO Jefferies
2/21/19	Initiated	Buy	X
HEXO HEXO Seaport Global Securities
$12
2/19/19	Initiated	Outperform	X
HEXO HEXO Oppenheimer
$7